The "reset button" revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients

The "reset button" revisited: why high activity ¹³¹I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients

Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):915-917. doi: 10.1007/s00259-017-3649-9. Epub 2017 Feb 16.

¹ Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany. verburg@med.uni-marburg.de.
² Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
³ Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
⁴ Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
⁵ Department of Nuclear Medicine, Istituto Nazionale Tumori IRCCS Foundation, Milan, Italy.
⁶ LUNAM Université, Oniris, «AMaROC», Nantes, France.
⁷ The Royal Marsden Hospital & Institute of Cancer Research, London, England.

No abstract available